不同APC基因狀態大腸直腸癌患者藥物治療之抗藥性機轉研究-合併 tetrac-與 cetuximab-誘導抑制APC基因功能異常之大腸直腸癌細胞增生(1/3)

Medicine & Life Sciences

1. tetraiodothyroacetic acid 100%
2. Cetuximab 77%
3. Adenomatous Polyposis Coli 38%
4. Colorectal Neoplasms 28%
5. Integrins 16%
6. Catenins 11%
7. Cell Culture Techniques 10%
8. Perfusion 10%
9. Immunoblotting 8%
10. Heterografts 7%
11. ras Genes 5%
12. Triple Negative Breast Neoplasms 5%